MY6200051A - 6-chloro-7-sulphamyl-3:4-dihydro-1:2:3-benzothiadiazine-1:1-dioxide and its salts and the preparation thereof - Google Patents
6-chloro-7-sulphamyl-3:4-dihydro-1:2:3-benzothiadiazine-1:1-dioxide and its salts and the preparation thereofInfo
- Publication number
- MY6200051A MY6200051A MY51/62A MY6200051A MY6200051A MY 6200051 A MY6200051 A MY 6200051A MY 51/62 A MY51/62 A MY 51/62A MY 6200051 A MY6200051 A MY 6200051A MY 6200051 A MY6200051 A MY 6200051A
- Authority
- MY
- Malaysia
- Prior art keywords
- sulphamyl
- benzothiadiazine
- dihydro
- chloro
- dioxide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
- C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
- C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
- C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
- C07D285/26—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals
- C07D285/28—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
- C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
- C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
- C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
- C07D285/26—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals
- C07D285/30—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals with hydrocarbon radicals, substituted by hetero atoms, attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71845258A | 1958-03-03 | 1958-03-03 | |
| US72724258A | 1958-04-09 | 1958-04-09 | |
| US74058258A | 1958-06-09 | 1958-06-09 | |
| US75162058A | 1958-07-29 | 1958-07-29 | |
| US76448258A | 1958-09-29 | 1958-09-29 | |
| DEC0028408 | 1959-02-27 | ||
| DEC0028409 | 1959-02-27 | ||
| DEC0024176 | 1959-02-27 | ||
| DEC0024178 | 1959-02-27 | ||
| DEC0024177 | 1959-02-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY6200051A true MY6200051A (en) | 1962-12-31 |
Family
ID=27579177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MY51/62A MY6200051A (en) | 1958-03-03 | 1962-12-30 | 6-chloro-7-sulphamyl-3:4-dihydro-1:2:3-benzothiadiazine-1:1-dioxide and its salts and the preparation thereof |
Country Status (6)
| Country | Link |
|---|---|
| CH (4) | CH371454A (en) |
| DE (4) | DE1445005A1 (en) |
| FR (2) | FR1217929A (en) |
| GB (1) | GB861367A (en) |
| MY (1) | MY6200051A (en) |
| OA (2) | OA01178A (en) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3200117A (en) * | 1962-10-03 | 1965-08-10 | Hoffmann La Roche | Derivatives of 1, 2, 4-benzothiadiazine-7-sulfonamide-1, 1-dioxide |
| DE2642140C2 (en) * | 1976-09-20 | 1982-10-28 | Degussa Ag, 6000 Frankfurt | Process for the production of benzoyl cyanide |
| DE8700284U1 (en) * | 1987-01-07 | 1987-04-30 | Ernst Reiner GmbH & Co KG, 7743 Furtwangen | Post date stamp |
| US6943159B1 (en) | 1998-02-18 | 2005-09-13 | Neurosearch A/S | Compounds and their use as positive AMPA receptor modulators |
| RU2214405C2 (en) * | 1998-02-18 | 2003-10-20 | НьюроСёрч А/С | Novel compounds and their application as positive modulators of ampa-receptors |
| ES2362998T3 (en) | 2002-08-19 | 2011-07-18 | Pfizer Inc. | COMBINATION THERAPY FOR HYPERPROLIFERATIVE DISEASES. |
| JP4589919B2 (en) | 2003-03-07 | 2010-12-01 | シェーリング コーポレイション | Substituted azetidinone compounds, their formulations and uses for the treatment of hypercholesterolemia |
| ATE406364T1 (en) | 2003-03-07 | 2008-09-15 | Schering Corp | SUBSTITUTED AZETIDINONE DERIVATIVES, THEIR PHARMACEUTICAL FORMULATIONS AND THEIR USE IN THE TREATMENT OF HYPERCHOLESTEROLEMIA |
| US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
| US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| US8404896B2 (en) | 2006-12-01 | 2013-03-26 | Bristol-Myers Squibb Company | N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| US20100120694A1 (en) | 2008-06-04 | 2010-05-13 | Synergy Pharmaceuticals, Inc. | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| US7879802B2 (en) | 2007-06-04 | 2011-02-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| EP2321341B1 (en) | 2008-07-16 | 2017-02-22 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| AU2014255381A1 (en) | 2013-04-17 | 2015-10-08 | Pfizer Inc. | N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases |
| BR112015030326A2 (en) | 2013-06-05 | 2017-08-29 | Synergy Pharmaceuticals Inc | ULTRAPURE GUANYLATE CYCLASE C AGONISTS, METHOD OF MANUFACTURING AND USING THEM |
| WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
| MX2021008533A (en) | 2019-01-18 | 2021-08-19 | Astrazeneca Ab | Pcsk9 inhibitors and methods of use thereof. |
-
1958
- 1958-12-16 FR FR781736A patent/FR1217929A/en not_active Expired
-
1959
- 1959-02-19 CH CH6978359A patent/CH371454A/en unknown
- 1959-02-19 CH CH18463A patent/CH387642A/en unknown
- 1959-02-19 CH CH18163A patent/CH377365A/en unknown
- 1959-02-19 CH CH18063A patent/CH376514A/en unknown
- 1959-02-27 DE DE19591445005 patent/DE1445005A1/en active Pending
- 1959-02-27 DE DE19591445007 patent/DE1445007A1/en active Pending
- 1959-02-27 DE DEC18496A patent/DE1112079B/en active Pending
- 1959-02-27 DE DE19591445574 patent/DE1445574A1/en active Pending
- 1959-03-02 GB GB7209/59A patent/GB861367A/en not_active Expired
- 1959-03-03 FR FR788246A patent/FR1264468A/en not_active Expired
-
1962
- 1962-12-30 MY MY51/62A patent/MY6200051A/en unknown
-
1964
- 1964-12-31 OA OA51359A patent/OA01178A/en unknown
-
1965
- 1965-06-29 OA OA52080A patent/OA03826A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CH387642A (en) | 1965-02-15 |
| DE1445008A1 (en) | 1968-10-24 |
| DE1445574A1 (en) | 1969-01-16 |
| FR1264468A (en) | 1961-06-23 |
| CH376514A (en) | 1964-04-15 |
| GB861367A (en) | 1961-02-22 |
| CH371454A (en) | 1963-08-31 |
| CH377365A (en) | 1964-05-15 |
| DE1112079B (en) | 1961-08-03 |
| DE1445006A1 (en) | 1968-10-24 |
| FR1217929A (en) | 1960-05-06 |
| OA03826A (en) | 1971-12-24 |
| DE1445005A1 (en) | 1968-10-24 |
| DE1445006B2 (en) | 1975-05-07 |
| DE1445007A1 (en) | 1968-10-24 |
| OA01178A (en) | 1969-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY6200051A (en) | 6-chloro-7-sulphamyl-3:4-dihydro-1:2:3-benzothiadiazine-1:1-dioxide and its salts and the preparation thereof | |
| MY6400051A (en) | Dibenxocyclohepatriene derivatives | |
| CY268A (en) | Benzothiadiazine derivatives and their preparation | |
| Mendner | Nikodemus | |
| USD185872S (en) | Infant's dish | |
| CY253A (en) | 6-Chloro-7-Sulphamyl-3:4-Dihydro-1:2:3-Benzothiadiazine-1:1-Dioxide and its salts and the preparation thereof | |
| MY6400099A (en) | Steroid compounds and preparation thereof | |
| Pereljman | Zanimljiva geometrija | |
| CA557755A (en) | Glucosides and the preparation thereof | |
| Šternfeld | Veštački zemljini sateliti | |
| Petrović | Diferencijalni račun | |
| CA562108A (en) | Alkoxybenzylisoquinolines and salts thereof | |
| CA557116A (en) | Ar-chloro-ar-hydroxyindanes and the preparation thereof | |
| Becerra-Schmidt | Streichquartett No. 1 | |
| AU231293B2 (en) | Phenothiazines and preparation thereof | |
| AU248312B2 (en) | 3:4 dihydro-1:2:4-benzothiadiazine-1:1-dioxides | |
| FR1242720A (en) | The stop valve | |
| CA556860A (en) | Derivatives of 4,4'-dicarbethoxy-1,1'-ethylenedipiperazine and their salts | |
| CY238A (en) | Piperazine salt and its preparation | |
| AU232928B2 (en) | 43689/58 | |
| AU225811B2 (en) | 38940/58 | |
| CA555766A (en) | 15-hydroxy-testosterone and 10-normethyltestosterone compounds and the 15,17-diacyl derivatives | |
| AU3772258A (en) | Phenothiazines and preparation thereof | |
| AU4633259A (en) | 3:4 dihydro-1:2:4-benzothiadiazine-1:1-dioxides | |
| CA553675A (en) | Babies' high chairs |